SAN ANTONIO – Second-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with trastuzumab emtansine...
SAN ANTONIO – Patients with localized, hormone receptor-positive, HER2-low breast cancer treated with trastuzumab deruxtecan (T-DXd, Enhertu) in the...
SAN ANTONIO – Non-Hispanic Black women with hormone receptor (HR)-positive/HER2-negative, lymph node-positive breast cancer had worse outcomes compared to...
SAN ANTONIO – Residual tumors from Black patients with estrogen receptor (ER)-positive/HER2-negative primary breast cancer treated with neoadjuvant chemotherapy...
Assay can also help identify patients who may benefit from ovarian suppression therapy SAN ANTONIO – Among premenopausal women...
Patients were pre- or perimenopausal with hormone receptor-positive, HER2-negative tumors SAN ANTONIO – In patients with hormone receptor-positive, HER2-negative,...
Awareness varied between wine, beer, and liquor PHILADELPHIA – Despite conclusive research that shows that all alcoholic beverages, including...
SAN DIEGO – Patients with cancer who were living with human immunodeficiency virus (HIV) infection had increased epigenetic age—a...
SAN DIEGO – Survivors of childhood cancer who consumed more total sugar, added sugar, and sugar-sweetened beverages had more...
SAN ANTONIO – The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an...